|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-04
|
$347,563
|
$347,563
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$3,540
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$1,800
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$3,769
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$6,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$7,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$78,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$635
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$85,770
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
University of Virginia Cancer Center Support Grant
|
2P30CA044579-26
|
$2,574,504
|
$51,490
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S1
|
$125,000
|
$2,500
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S2
|
$104,087
|
$2,082
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-10S1
|
$124,964
|
$4,999
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-10S2
|
$629,550
|
$25,182
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-10
|
$2,266,216
|
$90,649
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S1
|
$60,000
|
$2,400
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S2
|
$125,000
|
$5,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S3
|
$241,905
|
$9,676
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S4
|
$101,773
|
$4,071
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S5
|
$253,858
|
$10,154
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
5P30CA177558-05
|
$2,107,000
|
$84,280
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
Translational Research in Cancer
|
3P30CA056036-18S1
|
$58,442
|
$1,753
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-18S2
|
$117,000
|
$3,510
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-18S3
|
$175,000
|
$5,250
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-18
|
$2,807,751
|
$84,233
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Transcriptional Control of Leukemic Evolution in Primary Myelofibrosis
|
5R21CA195665-02
|
$174,000
|
$174,000
|
NAORA, HONAMI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Transcription and Splicing Dynamics in Single Cells
|
ZIA BC 011383
|
$950,432
|
$95,043
|
Larson, Daniel
|
CCR (NCI)
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
5R01CA166280-05
|
$318,513
|
$318,513
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
The role of Sin3B in normal and malignant hematopoietic stem cell functions
|
5F30CA203047-02
|
$49,044
|
$49,044
|
CANTOR, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
|
5R01CA174205-05
|
$320,588
|
$320,588
|
EKLUND, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
|
5R00CA181488-04
|
$249,000
|
$249,000
|
LOSMAN, JULIE
|
DANA-FARBER CANCER INST
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S1
|
$204,369
|
$8,175
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S2
|
$57,797
|
$2,312
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S3
|
$79,482
|
$3,179
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$194,626
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
|
5R01CA167169-05
|
$321,625
|
$321,625
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Targeting PML for Leukemia Therapy
|
5R01CA142874-07
|
$465,791
|
$465,791
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting of Tyrosine Phosphatase SHP2 in Myeloproliferative Neoplasms
|
7R21CA202544-03
|
$181,974
|
$181,974
|
MOHI, GOLAM
|
UNIVERSITY OF VIRGINIA
|
|
Targeting of Tyrosine Phosphatase SHP2 in Myeloproliferative Neoplasms
|
5R21CA202544-02
|
|
$0
|
MOHI, GOLAM
|
UPSTATE MEDICAL UNIVERSITY
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$380,715
|
$95,179
|
Tosato, Giovanna
|
CCR (NCI)
|
|
STUDIES OF BCR-ABL LEUKEMOGENESIS IN MICE
|
2R01CA090576-17
|
$293,550
|
$293,550
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-04
|
$257,562
|
$257,562
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
|
5P50CA100632-15
|
$2,300,000
|
$92,000
|
KANTARJIAN, HAGOP
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE in Myeloid Malignancies
|
1P50CA206963-01A1
|
$2,185,000
|
$262,200
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Sphingolipids in Cancer Biology and Therapy
|
5P01CA097132-14
|
$1,301,994
|
$182,279
|
HANNUN, YUSUF
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$591,339
|
$236,536
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
|
5U54CA193419-03
|
$1,762,723
|
$810,853
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
|
5R01CA175215-05
|
$579,042
|
$579,042
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Single cell cytokine analysis of circulating malignant hematopoietic cells
|
5R33CA196411-03
|
$394,241
|
$394,241
|
FAN, RONG
|
YALE UNIVERSITY
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $16,629,705
|